PL81014B1 - - Google Patents
Download PDFInfo
- Publication number
- PL81014B1 PL81014B1 PL14127270A PL14127270A PL81014B1 PL 81014 B1 PL81014 B1 PL 81014B1 PL 14127270 A PL14127270 A PL 14127270A PL 14127270 A PL14127270 A PL 14127270A PL 81014 B1 PL81014 B1 PL 81014B1
- Authority
- PL
- Poland
- Prior art keywords
- mixture
- thiophosphamide
- alkaloids
- boiling point
- product
- Prior art date
Links
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 26
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 18
- FOCVUCIESVLUNU-UHFFFAOYSA-N Thiotepa Chemical class C1CN1P(N1CC1)(=S)N1CC1 FOCVUCIESVLUNU-UHFFFAOYSA-N 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 229930013930 alkaloid Natural products 0.000 claims description 13
- 229960001196 thiotepa Drugs 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 6
- 241001233914 Chelidonium majus Species 0.000 claims description 6
- INVGWHRKADIJHF-UHFFFAOYSA-N Sanguinarin Chemical compound C1=C2OCOC2=CC2=C3[N+](C)=CC4=C(OCO5)C5=CC=C4C3=CC=C21 INVGWHRKADIJHF-UHFFFAOYSA-N 0.000 claims description 6
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical compound OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 229940093265 berberine Drugs 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 claims description 4
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 claims description 4
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims description 4
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 claims description 3
- FCEXWTOTHXCQCQ-UHFFFAOYSA-N Ethoxydihydrosanguinarine Natural products C12=CC=C3OCOC3=C2C(OCC)N(C)C(C2=C3)=C1C=CC2=CC1=C3OCO1 FCEXWTOTHXCQCQ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- YZRQUTZNTDAYPJ-UHFFFAOYSA-N sanguinarine pseudobase Natural products C1=C2OCOC2=CC2=C3N(C)C(O)C4=C(OCO5)C5=CC=C4C3=CC=C21 YZRQUTZNTDAYPJ-UHFFFAOYSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- UUOCDFGUEXAVIL-UHFFFAOYSA-N Sanguinarin Natural products CNc1c(ccc2cc3OCOc3cc12)c4ccc5OCOc5c4C=O UUOCDFGUEXAVIL-UHFFFAOYSA-N 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 150000002537 isoquinolines Chemical class 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 150000001414 amino alcohols Chemical class 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000007098 aminolysis reaction Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229940084560 sanguinarine Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical group C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical class C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/564—Three-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/62—Isoquinoline or hydrogenated isoquinoline ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
- C07G5/00—Alkaloids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU1330542A SU368254A1 (ru) | 1969-06-16 | 1969-06-16 | Способ получения соединений тиофосфамида с алкалоидами чистотела большого |
Publications (1)
Publication Number | Publication Date |
---|---|
PL81014B1 true PL81014B1 (cs) | 1975-08-30 |
Family
ID=20445753
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14127270A PL81014B1 (cs) | 1969-06-16 | 1970-06-12 |
Country Status (9)
Country | Link |
---|---|
BE (1) | BE752064A (cs) |
CH (1) | CH553225A (cs) |
CS (1) | CS155618B1 (cs) |
FR (1) | FR2052972B1 (cs) |
GB (1) | GB1304064A (cs) |
PL (1) | PL81014B1 (cs) |
RO (1) | RO57382A (cs) |
SE (1) | SE367637B (cs) |
SU (1) | SU368254A1 (cs) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH695417A5 (de) | 2001-11-15 | 2006-05-15 | Ddr Wassyl Nowicky Dipl Ing | Verfahren zur Umsetzung von Alkaloiden. |
EP1459753A1 (en) | 2003-03-18 | 2004-09-22 | Nowicky, Wassyl, Dipl.-Ing. DDr. | Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments |
-
1969
- 1969-06-16 SU SU1330542A patent/SU368254A1/ru active
-
1970
- 1970-06-11 CH CH883470A patent/CH553225A/xx unknown
- 1970-06-12 PL PL14127270A patent/PL81014B1/pl unknown
- 1970-06-15 GB GB2882870A patent/GB1304064A/en not_active Expired
- 1970-06-15 SE SE828570A patent/SE367637B/xx unknown
- 1970-06-16 RO RO6364670A patent/RO57382A/ro unknown
- 1970-06-16 FR FR7022029A patent/FR2052972B1/fr not_active Expired
- 1970-06-16 BE BE752064D patent/BE752064A/xx unknown
- 1970-06-16 CS CS420870A patent/CS155618B1/cs unknown
Also Published As
Publication number | Publication date |
---|---|
GB1304064A (cs) | 1973-01-24 |
CH553225A (de) | 1974-08-30 |
SE367637B (cs) | 1974-06-04 |
DE2028330B2 (de) | 1977-02-03 |
BE752064A (fr) | 1970-12-16 |
RO57382A (cs) | 1975-01-15 |
DE2028330A1 (de) | 1971-05-27 |
SU368254A1 (ru) | 1973-01-26 |
FR2052972B1 (cs) | 1973-08-10 |
CS155618B1 (cs) | 1974-05-30 |
FR2052972A1 (cs) | 1971-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Deutsch et al. | Synthesis of congeners and prodrugs. 3. Water-soluble prodrugs of taxol with potent antitumor activity | |
CA2368815A1 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
Shealy et al. | Triazeno-v-triazole-4-carboxamides. Synthesis and Antitumor Evaluation1, 2 | |
US3865830A (en) | Thiophosphamide derivatives of isoquinoline alkaloids, method of producing and application thereof | |
US5747502A (en) | Process for preparing benzo c!phenanthridinium derivatives, novel compounds prepared by said process, and antitumor agents | |
PL81014B1 (cs) | ||
CH637961A5 (de) | Tricyclische chinazoline und verfahren zu ihrer herstellung. | |
US6545149B2 (en) | Synthesis and crystallization of piperazine ring-containing compounds | |
Heymann et al. | Derivatives of p, p'-Diaminodiphenyl Sulfone1a | |
CN103864781A (zh) | 一种新型1,9-二取代四氢咔啉类衍生物的制备及其抗肿瘤药物中的应用 | |
EP0487930B1 (en) | Benzo[C]phenanthridinium derivatives | |
Tatibouët et al. | Reaction of 3-amino-acridine with formaldehyde in acidic medium: Influence of the stoechiometry on the reaction products | |
US4298610A (en) | Ester derivatives of quinolopyran-4-one-2-carboxylic acids and antiallergic antasthmatics | |
US3682899A (en) | 1-oxo - 3-benzal-thiochromanone derivatives and a process for the production of these compounds | |
US3396164A (en) | Naphthoxazinones | |
JPH0114235B2 (cs) | ||
US3839568A (en) | Selected 5-substituted-5-phenylalkyl barbituric acids in analgetic compositions and methods of use | |
GB2099812A (en) | Process for the preparation of benz (e) indolines | |
Derieg et al. | 3-Amino-3, 4-dihydroquinazolines | |
CA1154027A (en) | Derivatives of benzo¬b| furan | |
AU781221B2 (en) | Novel synthesis and crystallization of piperazine ring-containing compounds | |
US3784547A (en) | Selected 5-substituted-5-phenylalkyl barbituric acids | |
McKee et al. | Some Basically Substituted Quinazolines | |
RU2059626C1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ТРИБРОМИДА ТРИС( β -ДИЭТИЛБЕНЗИЛАММОНИО)ЭТИЛОВОГО ЭФИРА ИЗОЦИАНУРОВОЙ КИСЛОТЫ | |
US3018286A (en) | Methoxy-z-j |